🇺🇸 FDA
Patent

US 8524718

Heteroaromatic derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors

granted A61PA61P1/00A61P1/04

Quick answer

US patent 8524718 (Heteroaromatic derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors) held by Addex Pharma, S.A. expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Addex Pharma, S.A.
Grant date
Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P1/00, A61P1/04, A61P1/06, A61P1/12